Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
T-Biotechnology, operating under the brand T-LAB, is a biotechnology company focused on the development and manufacture of regenerative medicine products and medical devices. Based in Turkey, the company specializes in autologous cell therapy systems, including high-efficiency Platelet-Rich Plasma (PRP) kits and Stromal Vascular Fraction (SVF) isolation technologies. Their products are utilized across various medical fields such as aesthetics, orthopedics, and wound care to promote tissue repair and healing. T-Biotechnology maintains international quality standards, holding ISO 13485 certification and CE marking for its medical devices. The company maintains a global distribution network, providing standardized protocols and innovative tools for clinicians performing regenerative therapies. The company is recognized for its standardized protocols that ensure high concentrations of regenerative cells for clinical use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on T-Biotechnology Laboratory.